BNT162B2 mRNA新冠疫苗在心肺移植年轻成年人中的应用：是否需要另一种严重急性呼吸综合征冠状病毒2免疫反应监测方法？ - Suppr

BNT162B2 mRNA COVID-19 Vaccine in Heart and Lung Transplanted Young Adults: Is an Alternative SARS-CoV-2 Immune Response Surveillance Needed?

作者信息

Cotugno Nicola, Pighi Chiara, Morrocchi Elena, Ruggiero Alessandra, Amodio Donato, Medri Chiara, Colagrossi Luna, Russo Cristina, Di Cesare Silvia, Santilli Veronica, Manno Emma Concetta, Zangari Paola, Giancotta Carmela, Bernardi Stefania, Nicolosi Luciana, Ciofi Degli Atti Marta, Raponi Massimiliano, Zaffina Salvatore, Alfieri Sara, Kirk Richard, Perno Carlo Federico, Rossi Paolo, Amodeo Antonio, Palma Paolo

机构信息

Academic Department of Pediatrics (DPUO), Clinical and Research Unit of Clinical Immunology and Vaccinology, IRCCS Bambino Gesuù Children's Hospital, Rome, Italy.

Department of Systems Medicine, University of Rome "Tor Vergata," Rome, Italy.

出版信息

Transplantation. 2022 Feb 1;106(2):e158-e160. doi: 10.1097/TP.0000000000003999.

DOI:10.1097/TP.0000000000003999

PMID:34954734

Abstract

摘要

相似文献

BNT162B2 mRNA COVID-19 Vaccine in Heart and Lung Transplanted Young Adults: Is an Alternative SARS-CoV-2 Immune Response Surveillance Needed?

Transplantation. 2022 Feb 1;106(2):e158-e160. doi: 10.1097/TP.0000000000003999.

Dynamics of antibody response to BNT162b2 mRNA COVID-19 vaccine after 6 months.

J Travel Med. 2021 Dec 29;28(8). doi: 10.1093/jtm/taab173.

Eosinophilic cellulitis after BNT162b2 mRNA Covid-19 vaccine.

J Eur Acad Dermatol Venereol. 2022 Jan;36(1):e26-e28. doi: 10.1111/jdv.17685. Epub 2021 Oct 5.

Cutaneous reaction to BNT162b2 mRNA COVID-19 vaccine.

Int J Dermatol. 2021 Jul;60(7):891-892. doi: 10.1111/ijd.15575. Epub 2021 Apr 14.

Safety and BNT162b2 mRNA COVID-19 vaccination.

Acta Biomed. 2022 Jan 19;92(6):e2021485. doi: 10.23750/abm.v92i6.12359.

Dynamics of Antibody Response to BNT162b2 mRNA COVID-19 Vaccine: A 7-Month Follow-Up Study.

Medicina (Kaunas). 2021 Dec 5;57(12):1330. doi: 10.3390/medicina57121330.

Skin ulcer at the injection site of BNT162b2 mRNA COVID-19 vaccine.

J Dermatol. 2021 Dec;48(12):e596-e597. doi: 10.1111/1346-8138.16163. Epub 2021 Sep 21.

[Immune thrombocytopenia after BNT162b2 mRNA COVID-19 vaccination].

Rinsho Ketsueki. 2021;62(11):1639-1642. doi: 10.11406/rinketsu.62.1639.

Re: Short-term outcome of pregnant women vaccinated with BNT162b2 mRNA COVID-19 vaccine.

Ultrasound Obstet Gynecol. 2021 Dec;58(6):958. doi: 10.1002/uog.24811.

Humoral immune response after different SARS-CoV-2 vaccination regimens.

BMC Med. 2022 Jan 21;20(1):31. doi: 10.1186/s12916-021-02231-x.

引用本文的文献

Biomarkers of vaccine safety and efficacy in vulnerable populations: Lessons from the fourth international precision vaccines conference.

Vaccine. 2025 Jan 1;43(Pt 2):126477. doi: 10.1016/j.vaccine.2024.126477. Epub 2024 Nov 28.

Vaccinations in Paediatric Solid Organ Transplant Candidates and Recipients.

Vaccines (Basel). 2024 Aug 23;12(9):952. doi: 10.3390/vaccines12090952.

Duration of immunity to SARS-CoV-2 in children after natural infection or vaccination in the omicron and pre-omicron era: A systematic review of clinical and immunological studies.

Front Immunol. 2023 Jan 11;13:1024924. doi: 10.3389/fimmu.2022.1024924. eCollection 2022.

Immunogenicity of COVID-19 vaccines in solid organ transplant recipients: a systematic review and meta-analysis.

Clin Microbiol Infect. 2023 Apr;29(4):441-456. doi: 10.1016/j.cmi.2022.12.004. Epub 2022 Dec 9.

Immunosuppressant and SARS-CoV-2 Vaccine Antibody Response After Lung Transplantation.

Transplant Proc. 2022 Dec;54(10):2692-2697. doi: 10.1016/j.transproceed.2022.11.001. Epub 2022 Nov 15.

Humoral and cellular response of COVID-19 vaccine among solid organ transplant recipients: A systematic review and meta-analysis.

Transpl Infect Dis. 2022 Dec;24(6):e13926. doi: 10.1111/tid.13926. Epub 2022 Aug 12.

Analysis of Immunization, Adverse Events, and Efficacy of a Fourth Dose of BNT162b2 Vaccine in Health Workers in Mexico, a Pilot Study.

Vaccines (Basel). 2022 Jul 17;10(7):1139. doi: 10.3390/vaccines10071139.

Evaluation of Safety and Immunogenicity of BNT162B2 mRNA COVID-19 Vaccine in IBD Pediatric Population with Distinct Immune Suppressive Regimens.

Vaccines (Basel). 2022 Jul 11;10(7):1109. doi: 10.3390/vaccines10071109.

Perinatally Human Immunodeficiency Virus-Infected Adolescents and Young Adults Demonstrate Distinct BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine Immunogenicity.

Clin Infect Dis. 2022 Aug 15;75(Suppl 1):S51-S60. doi: 10.1093/cid/ciac408.

Benefit-risk evaluation of COVID-19 vaccination in special population groups of interest.

Vaccine. 2022 Jul 30;40(32):4348-4360. doi: 10.1016/j.vaccine.2022.05.067. Epub 2022 May 27.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

BNT162B2 mRNA COVID-19 Vaccine in Heart and Lung Transplanted Young Adults: Is an Alternative SARS-CoV-2 Immune Response Surveillance Needed?

作者信息

机构信息

Academic Department of Pediatrics (DPUO), Clinical and Research Unit of Clinical Immunology and Vaccinology, IRCCS Bambino Gesuù Children's Hospital, Rome, Italy.

Department of Systems Medicine, University of Rome "Tor Vergata," Rome, Italy.

出版信息

Transplantation. 2022 Feb 1;106(2):e158-e160. doi: 10.1097/TP.0000000000003999.

DOI:10.1097/TP.0000000000003999

PMID:34954734

Abstract

摘要

相似文献

BNT162B2 mRNA COVID-19 Vaccine in Heart and Lung Transplanted Young Adults: Is an Alternative SARS-CoV-2 Immune Response Surveillance Needed?

Transplantation. 2022 Feb 1;106(2):e158-e160. doi: 10.1097/TP.0000000000003999.

Dynamics of antibody response to BNT162b2 mRNA COVID-19 vaccine after 6 months.

J Travel Med. 2021 Dec 29;28(8). doi: 10.1093/jtm/taab173.

Eosinophilic cellulitis after BNT162b2 mRNA Covid-19 vaccine.

J Eur Acad Dermatol Venereol. 2022 Jan;36(1):e26-e28. doi: 10.1111/jdv.17685. Epub 2021 Oct 5.

Cutaneous reaction to BNT162b2 mRNA COVID-19 vaccine.

Int J Dermatol. 2021 Jul;60(7):891-892. doi: 10.1111/ijd.15575. Epub 2021 Apr 14.

Safety and BNT162b2 mRNA COVID-19 vaccination.

Acta Biomed. 2022 Jan 19;92(6):e2021485. doi: 10.23750/abm.v92i6.12359.

Dynamics of Antibody Response to BNT162b2 mRNA COVID-19 Vaccine: A 7-Month Follow-Up Study.

Medicina (Kaunas). 2021 Dec 5;57(12):1330. doi: 10.3390/medicina57121330.

Skin ulcer at the injection site of BNT162b2 mRNA COVID-19 vaccine.

J Dermatol. 2021 Dec;48(12):e596-e597. doi: 10.1111/1346-8138.16163. Epub 2021 Sep 21.

[Immune thrombocytopenia after BNT162b2 mRNA COVID-19 vaccination].

Rinsho Ketsueki. 2021;62(11):1639-1642. doi: 10.11406/rinketsu.62.1639.

Re: Short-term outcome of pregnant women vaccinated with BNT162b2 mRNA COVID-19 vaccine.

Ultrasound Obstet Gynecol. 2021 Dec;58(6):958. doi: 10.1002/uog.24811.

Humoral immune response after different SARS-CoV-2 vaccination regimens.

BMC Med. 2022 Jan 21;20(1):31. doi: 10.1186/s12916-021-02231-x.

引用本文的文献

Biomarkers of vaccine safety and efficacy in vulnerable populations: Lessons from the fourth international precision vaccines conference.

Vaccine. 2025 Jan 1;43(Pt 2):126477. doi: 10.1016/j.vaccine.2024.126477. Epub 2024 Nov 28.

Vaccinations in Paediatric Solid Organ Transplant Candidates and Recipients.

Vaccines (Basel). 2024 Aug 23;12(9):952. doi: 10.3390/vaccines12090952.

Duration of immunity to SARS-CoV-2 in children after natural infection or vaccination in the omicron and pre-omicron era: A systematic review of clinical and immunological studies.

Front Immunol. 2023 Jan 11;13:1024924. doi: 10.3389/fimmu.2022.1024924. eCollection 2022.

Immunogenicity of COVID-19 vaccines in solid organ transplant recipients: a systematic review and meta-analysis.

Clin Microbiol Infect. 2023 Apr;29(4):441-456. doi: 10.1016/j.cmi.2022.12.004. Epub 2022 Dec 9.

Immunosuppressant and SARS-CoV-2 Vaccine Antibody Response After Lung Transplantation.

Transplant Proc. 2022 Dec;54(10):2692-2697. doi: 10.1016/j.transproceed.2022.11.001. Epub 2022 Nov 15.

Humoral and cellular response of COVID-19 vaccine among solid organ transplant recipients: A systematic review and meta-analysis.

Transpl Infect Dis. 2022 Dec;24(6):e13926. doi: 10.1111/tid.13926. Epub 2022 Aug 12.

Analysis of Immunization, Adverse Events, and Efficacy of a Fourth Dose of BNT162b2 Vaccine in Health Workers in Mexico, a Pilot Study.

Vaccines (Basel). 2022 Jul 17;10(7):1139. doi: 10.3390/vaccines10071139.

Evaluation of Safety and Immunogenicity of BNT162B2 mRNA COVID-19 Vaccine in IBD Pediatric Population with Distinct Immune Suppressive Regimens.

Vaccines (Basel). 2022 Jul 11;10(7):1109. doi: 10.3390/vaccines10071109.

Perinatally Human Immunodeficiency Virus-Infected Adolescents and Young Adults Demonstrate Distinct BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine Immunogenicity.

Clin Infect Dis. 2022 Aug 15;75(Suppl 1):S51-S60. doi: 10.1093/cid/ciac408.

Benefit-risk evaluation of COVID-19 vaccination in special population groups of interest.

Vaccine. 2022 Jul 30;40(32):4348-4360. doi: 10.1016/j.vaccine.2022.05.067. Epub 2022 May 27.

BNT162B2 mRNA COVID-19 Vaccine in Heart and Lung Transplanted Young Adults: Is an Alternative SARS-CoV-2 Immune Response Surveillance Needed?

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

BNT162B2 mRNA COVID-19 Vaccine in Heart and Lung Transplanted Young Adults: Is an Alternative SARS-CoV-2 Immune Response Surveillance Needed?

作者信息

机构信息

出版信息

相似文献

引用本文的文献